European Commission approved a deal to purchase 80 million doses of Moderna coronavirus vaccine. American biotechnology company Moderna, with its mRNA vaccine could be delivered early the first quarter of 2021 if it secures approval from the European Medicines Agency (EMA) human medicines committee.
Editorial use only Contact your sales representative for commercial and promotional uses.License this clip
More footage filed by NurPhoto videographers.